Mesut ALTAN
(Hacettepe Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Ankara, Türkiye)
Burak ÇITAMAK
(Hacettepe Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Ankara, Türkiye)
Emin MAMMADOV
(Hacettepe Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Ankara, Türkiye)
NAİME MERİÇ KONAR
(Hacettepe Üniversitesi, Tıp Fakültesi, Biyoistatistik Anabilim Dalı, Ankara, Türkiye)
Bülent AKDOĞAN
(Hacettepe Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Ankara, Türkiye)
Haluk ÖZEN
(Hacettepe Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Ankara, Türkiye)
Yıl: 2020Cilt: 7Sayı: 2ISSN: 2148-9580Sayfa Aralığı: 83 - 87İngilizce

45 0
Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination
Objective: To reveal the significance of core length in current primary transrectal ultrasound-guided prostate biopsy (TRUS-PB) in patients with normal digital rectal examination. Materials and Methods: Data of 3520 patients, who received TRUS-PB between March 2002 and April 2015, were reviewed retrospectively. A total of 1627 primary biopsy patients with a normal digital examination and with no lesion in TRUS were included in the study. The mean core length was found by dividing the sum of the total core lengths by the core number. The relationships of cancer detection rate (CDR) with age, Prostate-specific antigen (PSA) value, prostate volume, number of cores (10 or 12 cores) and mean core length were investigated. Results: The mean patient age, PSA and prostate volume were 62.3±7.9 years, 9.1±7.8 ng/mL and 55.8±21 mL, respectively. Cancer was diagnosed in 394 patients (24.2%). The mean core length was 12.7±1.7 (4.3-21.5) mm. Ten- and 12- core biopsies were performed in 1068 (65.6%), and 559 (34.4%) patients, respectively. Older age, PSA, mean core length, number of cores and reduced prostate volume were found to be associated with CDR (p<0.001, p<0.001, p=0.006 p=0.043, and p<0.001, respectively). In the multivariate analysis, age, PSA, prostate volume, mean core length, and number of cores were found to be independent factors in CDR (p<0.001, p<0.001, p<0.001, p=0.006 and p=0.009, respectively). Conclusion: Age, PSA, prostate volume, and number of cores, together with core length, are independent risk factors for cancer detection in TRUSPB.
DergiAraştırma MakalesiErişime Açık
  • Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, Schröder FH, Scattoni V. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. European urology. 2010;58:851-864.
  • Boccon-Gibod L, van der Kwast TH, Montironi R, Boccon-Gibod L, Bono A. Handling and pathology reporting of prostate biopsies. European urology. 2004;46:177-181.
  • van der Kwast TH, Lopes C, Santonja C, Pihl CG, Neetens I, Martikainen P, Di Lollo S, Bubendorf L, Hoedemaeker RF; Members of the pathology committee of the European Randomised Study of Screening for Prostate Cancer. Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol. 2003;56:336-340.
  • Guichard G, Larre S, Gallina A, Lazar A, Faucon H, Chemama S, Allory Y, Patard J-J, Vordos D, Hoznek A, Yiou R, Salomon L, Abbou CC, de la Taille A. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. European urology. 2007;52:430-435.
  • Lee S, Jeong SJ, Hwang SI, Hong SK, Lee HJ, Byun SS, Choe G, Lee SE. Clinical value of core length in contemporary multicore prostate biopsy. PloS one. 2015;10:e0123704.
  • Shariat SF, Roehrborn CG. Using biopsy to detect prostate cancer. Rev urol. 2008;10:262-280.
  • Chang JJ, Shinohara K, Bhargava V, Presti JC, Jr. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. The Journal of urology. 1998;160:2111-2114.
  • Epstein JI, Walsh PC, Carter HB. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology. 2001;57:1112-1116.
  • Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175:1605-1612.
  • Satoh T, Matsumoto K, Fujita T, Tabata K, Okusa H, Tsuboi T, Arakawa T, Irie A, Egawa S, Baba S. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology. 2005;66:114-118.
  • Ficarra V, Martignoni G, Novella G, Cerruto MA, Galfano A, Novara G, Pea M, Artibani W. Needle core length is a quality indicator of systematic transperineal prostate biopsy. European urology. 2006;50:266-271.
  • Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology. 2003;61:961-966.
  • Hara R, Jo Y, Fujii T, Kondo N, Yokoyoma T, Miyaji Y, Nagai A. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology. 2008;71:191-195.
  • Merrick GS, Irvin S, Fiano R, Anderson R, Butler WM, Adamovich E. Pathology and Quality of Life Outcomes Following Office-based Transperineal Prostate Biopsy. Urology 2016;94:24-28.
  • Iczkowski KA, Casella G, Seppala RJ, Jones GL, Mishler BA, Qian J, Bostwick DG. Needle core length in sextant biopsy influences prostate cancer detection rate. Urology. 2002;59:698-703.
  • Fiset PO, Aprikian A, Brimo F. Length of prostate biopsy cores: does it impact cancer detection? The Can J Urol. 2013;20:6848-6853.
  • Obek C, Doganca T, Erdal S, Erdogan S, Durak H. Core length in prostate biopsy: size matters. J Urol. 2012;187:2051-2055.
  • Reis LO, Sanches BC, de Mendonca GB, Silva DM, Aguiar T, Menezes OP, Billis A. Gleason underestimation is predicted by prostate biopsy core length. World J Urol. 2015;33:821-826.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.